IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, it offers diagnostic tests, services, and related instrumentation for manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

IDEXX Laboratories Inc.

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Idexx Laboratories (IDXX) and Alcon (ALC). Idexx Laboratories (ID...

Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX) and Alcon (ALC)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alkermes (ALKS) and Idexx Laboratories (IDXX) with b...

Wall Street Analysts Are Bullish on Top Healthcare Picks

Bank of America Securities analyst Michael Ryskin maintained a Hold rating on Idexx Laboratories today and set a price target of $790.00. According...

Current Yield	N/A	Payout Ratio	0.00%
Annual DPS	$0.00	Growth Streak	0 years
Ex-Dividend	Invalid Date	Pay Date	Invalid Date
Record Date	N/A	Declaration	N/A
Frequency	NA	Quarterly Est	$0.00

	A	B	C	D
1	Symbol	Price	Change	Volume
2	IDXX	$559.37	+1.14%	466.00K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	IDXX	$559.37	+1.1%	466.00K
3
4
5
6

IDXX

IDXX

Dividend Overview

Get IDEXX Laboratories Inc. Data in Excel

Get IDEXX Laboratories Inc. Data in Excel